Procept Biorobotics Corp reports results for the quarter ended June 30 - Earnings Summary

PROCEPT BioRobotics

04/08/2026 22:41

Procept Biorobotics Corp PRCT.OQ reported a quarterly adjusted loss of 47 cents​​ per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of -35 cents.  The mean expectation of fourteen analysts for the quarter was for a loss of 46 cents per share. Wall Street expected results to range from -51 cents to -36 cents per share.
Revenue rose 19.3% to $94.50 million from a year ago; analysts expected $92.89 million. 
Procept Biorobotics Corp's reported EPS for the quarter was a loss of 47 cents​.
The company reported a quarterly loss of $26.86 million.
Procept Biorobotics Corp shares had fallen by 18.6% this quarter and lost 41.6% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 3.3% in the last three months.​ 
In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 7 "strong buy" or "buy," 7 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy" 
Wall Street's median 12-month price target for Procept Biorobotics Corp is $29.50, about 37.7% above its last closing price of $18.38
This summary was machine generated from LSEG data August 4 at 09:41 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.46
-0.47
Missed
Mar. 31 2026 
-0.56
-0.56
Met
Dec. 31 2025 
-0.32
-0.53
Missed
Sep. 30 2025 
-0.41
-0.38
Beat